Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TKAFTER: Ropivacaine for Chronic Pain After Total Knee Replacement
NCT03998813Completed
- Sponsor
- CHD Vendée
- Start
- Sep 2020
- Primary completion
- Jun 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised trial of ropivacaine in chronic postsurgical pain (CPSP) (2 arms), sponsored by CHD Vendée. Primary endpoint: Walking Pain Assessment Scale at 3 months. Started Sep 2020; status: completed.
02
Drugs
ropivacaine
03
Conditions
chronic postsurgical pain (CPSP)
Beyond the preview
Go deeper on NCT03998813.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03998813.